Background: The fractional exhaled nitric oxide (FeNO) test is a point-of-care test that is
used in the assessment of asthma. Objective: To provide evidence-based clinical guidance …

Abstract The Saudi Initiative for Asthma 2021 (SINA-2021) is the fifth version of asthma
guidelines for the diagnosis and management of asthma for adults and children, which is …

Further research is needed to explore the diagnostic and therapeutic potential of epigenetic
modifications in asthma. Multiomics studies on asthma will become increasingly important …

Corticosteroid resistance causes significant morbidity in asthma, and drug repurposing may
identify timely and cost-effective adjunctive treatments for corticosteroid resistance. In 95 …

Inhaled corticosteroids (ICS) are a mainstay of treatment in eosinophilic asthma. Many
studies have explored the dose‐response effect of different formulations of ICS through …

B-cell activation factor (BAFF) and a proliferation-inducing ligand (APRIL) are members of
the tumor necrosis factor superfamily of cytokines and can induce B cell activation …

Inhaled corticosteroids (ICS) are the most common asthma controller medication. An
important contribution of genetic factors in ICS response has been evidenced. Here, we …

Background Fractional exhaled nitric oxide (FeNO) is a biomarker for eosinophilic
inflammation used for diagnosis and monitoring of asthma. High FeNO indicates significant …

Background and objective Fractional exhaled nitric oxide (FeNO) is a non‐invasive
biomarker that reflects IL‐4/IL‐13 production and therefore represents T2 allergic …

Eosinophils are a type of granulocyte with eosinophilic granules in the cytoplasm that play
an important role in allergic and parasitic diseases. Eosinophils are important in the …